Effects of Sinomenine on the Expression of microRNA-155 in 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis in Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yu, Qiao ^a,b   Zhu, Siying ^a,b   Zhou, Rui ^a,b   Yi, Fengming ^a,b   Bing, Yuntao ^b   Huang, Sha ^a,b   Wang, Zixi ^b   Wang, Chunyu ^b   Xia, Bing ^a,b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; MICRORNA 155; MYELOPEROXIDASE; SINOMENINE; TRANSCRIPTION FACTOR C MAF; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; HISTOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; COLITIS; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; MORPHINANS; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884185225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073757     Document Type: Article

References (37)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, et al. (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142: 46-54.
2. Kaser A, Zeissig S, Blumberg RS, (2010) Inflammatory bowel disease. Annu Rev Immunol 28: 573-621.
3. Fiocchi C, (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
4. Strober W, Fuss I, Mannon P, (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117: 514-521.
5. Neurath MF, Finotto S, Glimcher LH, (2002) The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8: 567-573.
6. Strober W, Fuss IJ, Blumberg RS, (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20: 495-549.
7. Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W, (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182: 1281-1290.
8. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, et al. (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803.
9. Esteller M, (2011) Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
10. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
11. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
12. Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ, (2011) Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev 22: 141-147.
13. Takagi T, Naito Y, Mizushima K, Hirata I, Yagi N, et al. (2010) Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 25: 129-133.
14. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, et al. (2010) Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One 5: e13160.
15. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
16. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
17. Zhou H, Wong YF, Wang J, Cai X, Liu L, (2008) Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats. Biochem Biophys Res Commun 376: 352-357.
18. Chan K, Liu ZQ, Jiang ZH, Zhou H, Wong YF, et al. (2006) The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model. J Ethnopharmacol 103: 425-432.
19. Chen DP, Wong CK, Leung PC, Fung KP, Lau CB, et al. (2011) Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-alpha-activated human fibroblast-like synoviocytes in rheumatoid arthritis. J Ethnopharmacol 137: 457-468.
20. Mark W, Schneeberger S, Seiler R, Stroka DM, Amberger A, et al. (2003) Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection. Transplantation 75: 940-945.
21. Candinas D, Mark W, Kaever V, Miyatake T, Koyamada N, et al. (1996) Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model. Transplantation 62: 1855-1860.
22. Cheng H, Xia B, Guo Q, Zhang L, Wang F, et al. (2007) Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice. Int Immunopharmacol 7: 604-611.
23. Wu LH, Xu ZL, Dong D, He S, Yu H, (2011) Protective Effect of Anthocyanins Extract from Blueberry on TNBS-Induced IBD Model of Mice. Evid Based Complement Alternat Med 2011: 525462.
24. Shi R, Chiang VL, (2005) Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 39: 519-525.
25. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 25: 402-408.
26. Xiang G, (2009) Wen X, (2009) Wang H, (2009) Chen K, (2009) Liu H, (2009) Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis. J Surg Oncol 100: 708-712.
27. Banerjee A, Schambach F, DeJong CS, Hammond SM, Reiner SL, (2010) Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J Immunol 40: 225-231.
28. Podolsky DK, (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429.
29. Wang Q, Li XK, (2010) Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol. 11: 373-376.
30. Liu L, Riese J, Resch K, Kaever V, (1994) Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum. Arzneimittelforschung 44: 1223-1226.
31. Chua JH, Armugam A, Jeyaseelan K, (2009) MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 11: 189-199.
32. Rana TM, (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 8: 23-36.
33. Tang Y, Luo X, Cui H, Ni X, Yuan M, et al. (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60: 1065-1075.
34. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, et al. (2008) MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135: 1624-1635.
35. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102: 3627-3632.
36. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, et al. (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089.
37. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. (2007) Regulation of the germinal center response by microRNA-155. Science 316: 604-608.